Comments
India’s drug regulator may soon grant restricted emergency use authorisation for Moderna’s Covid-19 vaccine, official sources said on Tuesday.
Moderna has also informed that the US Government has agreed to donate a certain number of doses of the Moderna Covid-19 vaccine through COVAX to the Government of India for use and has sought approval from the Central Drugs Standard Control Organisation (CDSCO) for these vaccines.
India in talks to find ‘middle ground’ with Pfizer, others, for vaccine imports
Cipla request
Mumbai-based pharmaceutical firm Cipla, on behalf of the US pharma major, has requested for import and marketing authorisation of these jabs.
According to the sources, an approval is likely to come anytime as the CDSCO is in favour of doing so.
Close to commit over $1-b to Moderna for booster vaccine: Cipla to Govt
Cipla filed an application on Monday seeking permission for import of Moderna Covid-19 vaccine referring to DCGI notices dated April 15 and June 1 stating that if the vaccine is approved by the USFDA for EUA, the vaccine can be granted marketing authorisation without bridging trial and assessment of safety data of first 100 beneficiaries of vaccines shall be submitted before rolling out in immunisation programme.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.